Related Experiment Video
Updated: Jun 13, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Antithrombotic therapy for acute coronary syndrome]
1Department of Medicine (Cardiology), Tokai University School of Medicine.
Acute coronary syndrome (ACS) involves platelet aggregation and thrombin generation. Effective antithrombotic therapy, using antiplatelet and anticoagulant medications, is crucial for managing ACS and preventing future events.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pharmacology
Context:
- Acute coronary syndrome (ACS) pathogenesis involves atheroma rupture, leading to platelet aggregation.
- Thrombin is a key mediator in both platelet activation and fibrin clot formation during ACS events.
Purpose:
- To review the critical role of antithrombotic therapy in managing acute coronary syndrome.
- To discuss the importance of antiplatelet and anticoagulant agents in improving patient outcomes and preventing recurrent cardiovascular events.
Summary:
- Platelet accumulation at ruptured atheroma initiates ACS.
- Antithrombotic strategies, combining antiplatelet and anticoagulant therapies, are vital for acute management and secondary prevention.
- Established regimens may evolve with the advent of novel therapeutic agents.
Impact:
- Highlights the significance of antithrombotic therapy in ACS management.
- Suggests potential shifts in clinical practice towards newer antithrombotic medications.
- Emphasizes the ongoing need for effective treatments to improve prognosis in ACS patients.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
